Life Sciences Tools and Services
Company Overview of Accelovance, Inc.
Accelovance, Inc., a contract research organization (CRO), provides site management organization, patient recruitment, and clinical call center services. The company focuses on oncology, vaccines, and general medicine to pharmaceutical and biotech industries. Its CRO services include protocol development, project management, clinical trial monitoring, data management, biostatistics, pharmacovigilance, regulatory affairs, and medical writing services. The company also provides clinical call center services, such as recruitment/retention/compliance, post approval safety studies, phase IV studies, surveillance programs, patient-reported outcomes, observational studies, registries, site support ...
2275 Research Boulevard
Rockville, MD 20850
Founded in 2004
Key Executives for Accelovance, Inc.
Senior Vice President of Clinical Development
Vice President of Business Development
Compensation as of Fiscal Year 2014.
Accelovance, Inc. Key Developments
Accelovance, Inc. Appoints Joseph D. Purvis as Vice President of Medical Affairs, Oncology
Sep 30 14
Accelovance, Inc. announced that Dr. Joseph D. Purvis has joined the company as Vice President Medical Affairs, Oncology. Dr. Purvis brings more than 25 years of oncology drug development experience to Accelovance, having provided significant contribution in the development, approval, and postmarketing development of multiple cytotoxic, biological, targeted, and hormonal products; including: IV Alkeran, IV Zyloprim, Navelbine, Eloxatin, Nolvadex, Faslodex, Arimidex, Casodex, Iressa, and Torisel. He has extensive regulatory experience, especially with the FDA and EMA, and has worked with community and academic oncologists and oncology cooperative groups. Dr. Purvis is an alumnus of Haverford College and of Jefferson Medical College. Dr. Purvis will be based in Accelovance's Raleigh Durham, NC office.
Accelovance Announces Opening of Research Triangle Park, North Carolina Office
Feb 19 14
Accelovance announced the opening of a new office in Research Triangle Park (RTP), North Carolina. This office opening supports continued corporate expansion and provides Accelovance's clients and employees with a presence in the research-active landscape of the RTP area of North Carolina. The new offices are close to many current and potential clients and offer a rich base of technical talent to support continued corporate growth. Accelovance plans to add up to 15 new clinical operations positions in the RTP area in 2014.
Accelovance Joins iMedNet Partner Program
Sep 26 13
MedNet Solutions announced that Accelovance has joined the iMedNet(TM) Partner Program. Designation as an iMedNet Partner will facilitate Accelovance's ability to offer iMedNet EDC to clients as an advanced solution for the data management needs associated with clinical trial programs while providing significant cost savings compared with similar platforms. Accelovance's focus on providing the best fit solutions and operational expertise has been a key driver in the growth trajectory of the company. With their acquisition of Radiant Research to bolster their General Medicine experience, continued leadership position in the conduct of Vaccine trials, and key additions to their scientific and operational Oncology staff, they continue on a path of significant expansion.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|